GlaxoSmithKline

US · GSK #177 by market cap Listed 1970 -1.82%

49.80 -0.93 -1.82%

Live - 304 symbols - heartbeat 426s ago · 2026-09-23 15:50

Pre-market 50.22 -0.99%

After-hours 50.72 0.00%

Overnight 50.28 -0.87%

Market cap: 99.76B
P/E (TTM): 15.84
P/B: 4.24
EPS: 3.71
Div yield: 3.56%
52W pos: 51%

Reader sentiment Are you bullish or bearish on GSK?

Anonymous reader poll. Unscientific, not investment advice.

About GlaxoSmithKline

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

CEO: Mr. Luke Miels
Employees: 66,841
Headquarters: London, Greater London, United Kingdom of Great Britain and Northern Ireland (the)
Fiscal year end: 12-31
Website: gsk.com

View SEC filings on EDGAR ›

Company profile

Exchange: US
Symbol: GSK
Market-cap rank: #177
Listing date: 1970-01-01
Market cap: 99.76B
Float cap: 96.65B
Shares out: 2.00B
Float shares: 1.94B

Sectors & themes

Drug Manufacturers - General CAR-T Therapy Infectious Disease Fractional Shares JP Star Stocks

Browse all sectors & themes

Quote time 2026-09-23 15:50:01 · For reference only, not investment advice.